All deCODE tests have been validated through clinical trials involving thousands of patients and controls from multiple populations, and have received full regulatory approval. Eastern Biotech aims to become a leading provider of deCODE tests in the UAE and other Middle Eastern Countries. In the past, Eastern Biotech has introduced to the Middle East products such as CancerSafe, genomic profile tests, family ancestry and other DNA tests.
This new range of deCODE genetics tests from type 2 diabetes to common cancers add a whole new dimension to its current range of Predictive Genetic tests. "Eastern Biotech is committed to provide advanced healthcare solutions to the region" said Dr. Sanjida Ahmed, Director of Research at Eastern Biotech. "We are constantly on the search for new breakthroughs and we are proud of our collaboration with deCODE. We are very excited to be offering this new and growing product range, which is going to be very useful for the UAE and Middle East populations,” she added. Pankaj Sohaney, Manager Marketing said: "The demand for genetic testing services in the region is increasing. We receive regular enquiries from all GCC countries. This partnership ensures that we are able to provide our customers with the widest range of high quality genetic tests."
Genetic testing is becoming an increasingly important component of modern healthcare as the focus shifts from intervention to prevention. An awareness of clinical predisposition to the development of disease provides us critical lead time for the implementation of vital pre-emptive and precautionary measures such as dietary factors, detailed screening or pharmaceutical intervention. Eastern Biotech’s agreement with deCODE ensures that local clinicians can provide their patients with the most accurate and timely information to delay or prevent the onset of diseases such as diabetes, heart disease and certain cancers.
See also www.easternbiotech.com and www.decode.com and www.decodediagnostics.com For the company's pioneering personal genome analysis service, integrating the genetic variants included in these tests and those linked to another 20 common diseases, see www.decodeme.com; and on its blog at www.decodeyou.com
